POSTER SESSION I - STOWELL-ORBISON AWARDS COMPETITION
Monday, March 26, 2007 — 9:30 AM - 12:00 Noon
Convention Center, Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
DERMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
58
Evaluation of CD10 Expression in Spindle Cell Lesions of the Skin with Emphasis on Atypical Fibroxanthoma
(389)
CA Abbud, M Bansal, CK Ma, A Ormsby, MW Lee - Henry Ford Health System, Detroit, MI
Diagnostic Value of CD23 in Merkel Cell Carcinoma and Small Cell Carcinoma
(397)
JC Carvalho, D Fullen, L Lowe, L Su, L Ma - University of Michigan, Ann Arbor, MI
WT1 Expression in Malignant Melanoma Is Associated with Aggressive Behavior
(405)
LJ Eisengart, HG Strawn, BP Adley - Feinberg School of Medicine, Northwestern University, Chicago, IL
Suppression of the Tumorigenicity of B-16V Melanoma Cells Transfecting with pHM6 Vector Carrying Mouse Lysozyme Gene
(410)
AI Guzel, H Kasap, I Tuncer, K Ozgunen, Y Sertdemir, M Kasap, N Ozcan - Cukurova University, Medical School, Adana, Turkey; Turkey; Adana, Turkey; Faculty of Agriculture, Turkey
Critical Domains of a6β4 Integrin for Squamous Cell Carcinoma Progression
(413)
BA Horst, A Russell, N Nguyen, MP Marinkovich - Columbia University School of Mdicine, New York, NY; Stanford University School of Medicine, Stanford, CA; Cytokinetics, South San Francisco, CA
Genetically Heterogeneous and Clonally Unrelated Metastases May Arise in Patients with Cutaneous Melanoma
(414)
TM Katona, TD Jones, M Wang, JN Eble, SD Billings, L Cheng - Indiana University, Inidanapolis, IN
Gene Expression Microarray System Used as a Molecular Diagnostic Tool To Distinguish Malignant Melanoma vs Benign Nevi from FFPE Tissue
(420)
SS Koh, P Abrishami, J Wei, M Opel, M Gorre, SW Binder - UCLA, Los Angeles, CA; Irvine, CA
The Utility of PU.1 as an Immunohistochemical Marker for Histiocyte Lesions of the Skin
(427)
DM Muirhead, MS Stone, SI Syrbu - University of Iowa, Iowa City, IA
FUS Flourescence In-Situ Hybridization Is Useful for Differentiating Cutaneous Low-Grade Fibromyxoid Sarcoma from Other Superficial Fibromyxoid Neoplasms
(429)
RM Patel, E Downs-Kelly, JC Fanburg-Smith, SD Billings, RR Tubbs, JR Goldblum - The Cleveland Clinic, Cleveland, OH; Armed Forces Institute of Pathology, Washington, DC; Indiana University School of Medicine, Indianapolis, IN
K Homology Domain Containing Protein Overexpressed in Cancer Is Expressed in Malignant Melanoma but Not in Melanocytic Nevi
(431)
JG Pryor, PA Bourne, BO Spaulding, GA Scott, H Xu - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA
Diagnostic Value of WT-1 and CD34 in Cutaneous Spindle Cell Neoplasms
(434)
SM Share, HM Singh, CD Deng, JF Silverman, RS Saad, YL Liu - Allegheny General Hospital, Pittsburgh, PA; University of North Carolina at Chapel Hill, Chapel Hill, NC
Tetraspanins in Malignant Melanoma
(438)
JW Turner, KE Youens, KB Johnson, JL Burchette, RT Vollmer, MA Selim - Duke University Medical Center, Durham, NC; Durham VA, Durham, NC
button next to any title to add to Itinerary Planner...
Add
